BARI, ELIA
 Distribuzione geografica
Continente #
NA - Nord America 1.815
EU - Europa 882
AS - Asia 544
AF - Africa 4
OC - Oceania 4
SA - Sud America 2
Totale 3.251
Nazione #
US - Stati Uniti d'America 1.780
CN - Cina 523
IE - Irlanda 497
IT - Italia 159
DE - Germania 83
FI - Finlandia 63
CA - Canada 35
SE - Svezia 27
BE - Belgio 19
FR - Francia 19
GB - Regno Unito 7
BD - Bangladesh 5
IN - India 4
JP - Giappone 4
MU - Mauritius 4
NL - Olanda 4
AU - Australia 3
RU - Federazione Russa 3
BR - Brasile 2
HK - Hong Kong 2
SG - Singapore 2
TH - Thailandia 2
CH - Svizzera 1
IR - Iran 1
MY - Malesia 1
NZ - Nuova Zelanda 1
Totale 3.251
Città #
Chandler 541
Dublin 491
Ashburn 217
Nanjing 114
Princeton 90
Lawrence 89
Medford 88
Beijing 77
Shanghai 67
Wilmington 64
Helsinki 60
New York 60
Ann Arbor 55
Pavia 47
Nanchang 42
Dearborn 36
Shenyang 36
Hebei 34
Toronto 34
Changsha 32
Hangzhou 30
Jiaxing 30
Washington 28
Jacksonville 21
Brussels 17
Piemonte 16
Redwood City 14
Tianjin 14
Los Angeles 11
Norwalk 10
Fairfield 8
Kunming 8
Woodbridge 8
Xian 7
Boardman 6
Des Moines 6
Frankfurt am Main 6
Padova 6
San Mateo 6
Travaco Siccomario 6
Berlin 5
Cambridge 5
Dhaka 5
Hefei 5
Houston 5
Ningbo 5
Rome 5
Cagliari 4
Esslingen am Neckar 4
Jinan 4
Milan 4
Tokyo 4
Brescia 3
Chengdu 3
Dallas 3
Falkenstein 3
Guangzhou 3
Orange 3
Piscataway 3
Zhengzhou 3
Adelaide 2
Borås 2
Böblingen 2
Cedar Knolls 2
Como 2
Cornigliano 2
Gent 2
Guidonia 2
Leawood 2
Legnano 2
Mantova 2
Munich 2
Phoenix 2
Redmond 2
Rockville 2
Seattle 2
Sovizzo 2
Stockholm 2
Taizhou 2
Terracina 2
Turin 2
West Jordan 2
Yonkers 2
Abbiategrasso 1
Andover 1
Ardabil 1
Auckland 1
Ban Nong Sala 1
Bangkok 1
Buccinasco 1
Chiasso 1
Chicago 1
College Park 1
Farra di Soligo 1
Fuzhou 1
Huizen 1
Kronberg 1
Markham 1
Melbourne 1
Melegnano 1
Totale 2.674
Nome #
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 76
Lyosecretome for use in the treatment of autoimmune diseases 76
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 67
Silk sericin and platelet lysate for intervertebral disc cell culture 65
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 59
Processo per isolare e liofilizzare vescicole extracellulari 58
Silk fibroin nanoparticles for Celecoxib and Curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthrit 57
3D Bioprinted Scaffolds Containing Mesenchymal Stem/Stromal Lyosecretome: Next Generation Controlled Release Device for Bone Regenerative Medicine 56
Combining Inulin and Cyclodextrin for colon drug release 55
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 53
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 51
Silk fibroin nanoparticles for Celecoxib and Curcumin delivery: in vitro efficacy in an osteoarthritis model 51
Equine freeze-dried secretome for joint regeneration in veterinary medicine: production process and in vitro efficacy 51
Cross-linked silk sericin microparticles as bioactive delivery system: formulation and in vitro cytotoxicity 50
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 50
Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles 50
Isolation and characterization of B. mori silk sericin for topical applications 49
Freeze-dried pharmaceutical formulations containing mesenchymal exosomes for acellular MSC immunomodulant therapy 49
Canine mesenchymal Lyosecretome production and clinical use in osteoarthritic dogs. 48
Controlled release of celecoxib from inulin based micelles 47
Sericin microparticles as bioactive carriers for local drug delivery: in vitro cytocompatibility profile 47
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 47
Efficacy of a freeze-dried product based on MSC-secretome (Lyosecretome) in a wound healing murine model. 46
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 45
Canine lyo-secretome for osteoarticular regeneration in veterinary medicine: pilot-production and in vitro efficacy 45
3D Bioprinted Scaffolds for controlled release of Mesenchymal Stem/Stromal Lyo-secretome in Bone Regeneration 45
In vitro cytotoxicity and potency of freeze-dried MSC-secretome (Lyosecretome). 44
Association of silk sericin and platelet lysate: Premises for the formulation of wound healing active medications 44
Characterization and antioxidant activity of essential oil of four sympatric orchid species 44
Equine Mesenchymal Stem/Stromal Cells Freeze-Dried Secretome (Lyosecretome) for the Treatment of Musculoskeletal Diseases: Production Process Validation and Batch Release Test for Clinical Use 44
Biohybrid bovine bone matrix for controlled release of mesenchymal stem/stromal cell lyosecretome: A device for bone regeneration 44
Human engineered cartilage and decellularized matrix as an alternative to animal osteoarthritis model 43
Freeze-dried MSC-secretome (Lyosecretome) for regenerative medicine applications: pharmaceutical development. 42
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine: in vitro cytotoxicity and potency 41
Freeze-dried and GMP-compliant pharmaceuticals containing mesenchymal exosomes for acellular MSC immunomodulant therapy 41
Scaffold for tissue regeneration, particularly for bone regeneration, and manufacturing method thereof. 41
In vitro efficacy of platelet lysate in association with silk sericin for intervertebral disk regeneration 40
Synthesis of differently bioconjugated novel c-RGD antagonist 40
From mesenchymal stem/stromal cells to cell products: pharmaceutical development of secretome as new biological medicinal product 40
Production, characterization, and in vitro efficacy of canine and equine lyo-secretome injectable formulation in regenerative medicine 40
Freeze-dried secretome from mesenchymal stromal cells: a phase I clinical trial for equine and canine musculoskeletal diseases 38
Auricchio F, Bari E, Conti M, Perteghella S, Scocozza F, Sorlini M, Torre ML. Scaffold per la rigenerazione tissutale, in particolare per la rigenerazione ossea, e relativo metodo di fabbricazione. 38
Osteoinductive and osteoconductive properties of 3D Printed scaffolds containing Mesenchymal Stem/Stromal Lyosecretome 38
Production, characterization, and in vitro efficacy of a canine lyo-secretome injectable formulation for osteoarticular regeneration 37
Nanoparticles for use in the redirection against the tumour of a non-tumour-specific immune response, based on a pre-existing immunity 37
Pharmaceutical development of freeze-dried extracellular vesicles. 36
Chromatographic profiling of silk sericin for biomedical and cosmetic use by complementary hydrophylic, reversed phase and size exclusion chromatographic methods 36
Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy 35
Efficacy of sponge-like dressing containing MSC lyo-secretome in a wound healing murine model 35
From Bench to Bedside: The Long Way Towards GMP Scale-up, Preclinical and Clinical Trials for Silk-based Drug Delivery Systems 35
Canine mesenchymal stem cell lyo-secretome: in vitro potency evaluation and in vivo preliminary application in dogs with naturally occurring osteoarthritis 35
Technological Development of Freeze-dried Mesenchymal Stem Cell Secretome Formulations 35
Stem cell-extracellular vesicles loading silk/curcumin nanoparticles for drug delivery 34
Silk Fibroin Nanoparticle Functionalized with Arg-Gly-Asp cyclopentapeptide: Tumor specific Active Targeting 34
Osteoinductive and osteoconductive properties of titanium cages containing Mesenchymal Stem/Stromal Lyosecretome. 34
Sponge-like formulations containing MSC lyo-secretome: efficacy in a wound healing murine model 33
Silk sericin: from textile waste material to dermatological and cosmetic applications 33
From mesenchymal stem/stromal cells to cell products: pharmaceutical evelompment of secretome as new biological medicinal product 32
Silk Fibroin Nanoparticle to Redirected Immunity Against Cancer 32
Osteoinductive and osteoconductive properties of Biohybrid Bovine Bone Matrix containing Mesenchymal Stem/Stromal Cell Lyosecretome 32
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine: efficacy in a murine model of wound healing 31
Silk Fibroin Nanoparticle Functionalization with Arg-Gly-Asp cyclopentapeptide Promotes Active Targeting for Tumor Site-Specific Delivery 31
Preparation and characterization of polyphenols-loaded silk sericin self-assembling nanosystems 31
Pilot production of mesenchymal stem/stromal freeze-dried secretome for cell-free regenerative nanomedicine: a validated GMP-compliant process. 30
Alternative culture media and cold-drying for obtaining high biological value Arthrospira platensis (Cyanobacteria) 29
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? 29
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine 28
Silk-fibroin Micro-drug Delivery Systems 28
Silk 28
Scaffold for tissue regeneration, particularly for bone regeneration, and manufacturing method thereof. 28
Polyphenols-Loaded Sericin Self-Assembling Nanoparticles: A Slow-Release for Regeneration by Tissue-Resident Mesenchymal Stem/Stromal Cells 27
Silk-sericin Nano-drug Delivery Systems 27
GMP validation of production process for freeze-dried secretome from bone marrow mesenchymal stem/stromal cells 26
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. 25
Silk-fibroin Nano-drug Delivery Systems 25
Pharmaceutical development of mesenchymal extracellular vescicle formulations 24
Scaffold per la rigenerazione ossea e relativo metodo di fabbricazione 24
Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier? 23
Silk fibroin nanoparticles to redirect immunity against different cancers: proof of concept in a murine model. 22
Extracellular vesicles for lung regeneration in alpha-1-antitrypsin deficiency 20
From mesenchymal stem/stromal cells to cell products: pharmaceutical development of secretome as new biological medicinal product 19
Silk-sericin Micro-drug Delivery Systems 19
A new human platelet lysate for mesenchymal stem cell production compliant with Good Manufacturing Practice conditions preserve chemical characteristics and biological activity of lyo-secretome isolated by ultrafiltration 19
cRGD-Functionalized Silk Fibroin Nanoparticles: A Strategy for Cancer Treatment with a Potent Unselective Naphthalene Diimide Derivative 18
GMP validation of production process for freeze-dried secretome from bone marrow mesenchymal stem/stromal cells 18
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use 18
Silk-based Drug Delivery Systems 17
Growth Factors Delivery System for Skin Regeneration: An Advanced Wound Dressing 12
GMP-compliant sponge like dressing containing MSC lyo-secretome: proteomic network of healing in a murine wound model 12
GMP-compliant sponge-like dressing containing MSC lyo-secretome: proteomic network of healing in a murine wound model 10
Totale 3.378
Categoria #
all - tutte 14.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.551


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020557 139 235 10 27 7 9 24 32 20 27 23 4
2020/2021152 2 3 5 11 21 9 13 31 13 14 15 15
2021/2022492 1 3 51 10 6 21 6 31 24 5 98 236
2022/20231.400 191 113 29 99 95 143 4 64 600 8 26 28
2023/2024626 68 96 32 38 49 191 58 36 3 19 24 12
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 3.378